The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

A decision is expected in the fourth quarter of 2025.

The Bagsvaerd, Denmark, company said that if the application is approved, Wegovy would become the first oral formulation of a ...

A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...

Is Ozempic or Wegovy better for weight loss? We have answers. Ozempic is approved by the FDA (U.S. Food and Drug Administration) to help patients with type 2 diabetes control their blood sugar levels.

Prior to starting the trial, the participants also had moderate to high levels of scar tissue in the liver, known as stage 2 ...

Effective July 1, 2025, CVS Caremark will place Wegovy injection 2.4 mg as preferred on its commercial template formularies.

A late-stage clinical study showed that this weight loss drug helped 2 out of 3 people with the life-threatening liver ...

Weight loss pills either reduce appetite, boost metabolism or block fat absorption. Most people lose 5% to 10% of their body ...

If Wegovy or another weight loss medication is appropriate ... which is not recommended or approved by the FDA on-demand support for medication management navigates insurance coverage of GLP ...